Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin

• Status: Completed
• Trial end date: 2011-04-01

Summary

1. Explore pharmacodynamics

• glucose

• insulin

• C-peptide

• glucagon

• intact GLP-1

• DPP-4 activity

• CGMS (continuous glucose monitoring system)

2. Assess Safety

• adverse events

• clinical laboratory test

• physical examination

• Phase: Phase 1

Details

• Lead Sponsor: Samsung Medical Center
• Collaborator: JW Pharmaceutical
• Treatments: Mitiglinide; Sitagliptin Phosphate